Search research articles
Contact Us
Filters
Showing results (101-110 of 420) with videos related to
Page
of 42
Sort By:
Diagnostic Microbiology and Infectious Disease
|
July 13, 2004
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003)
Ronald N Jones, Lalitagauri Deshpande, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease
|
January 11, 2017
Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014)
Helio S Sader, Mariana Castanheira, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
July 13, 2019
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015-2017)
Helio S Sader, Mariana Castanheira, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy
|
August 12, 2020
<i>In Vitro</i> Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe
Cecilia G Carvalhaes, Leonard R Duncan, Wen Wang, et al.
Journal of Global Antimicrobial Resistance
|
June 11, 2025
Activity of Aztreonam-avibactam and Ceftazidime-avibactam against β-lactamase-producing Enterobacterales Isolates from United States Hospitals
Lalitagauri M Deshpande, Timothy B Doyle, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2011
Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes
Helio S Sader, Paul R Rhomberg, David J Farrell, et al.
Pathology
|
July 17, 2010
Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008)
Jan M Bell, John D Turnidge, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
December 21, 2002
Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers
Helio S Sader, Ronald N Jones, Soraya Andrade-Baiocchi, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009-2013)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
February 18, 2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012)
Robert K Flamm, David J Farrell, Helio S Sader, et al.
Page
of 42
Search research articles
Search
Showing results (101-110 of 420) with videos related to
Sort By:
Page
of 42
Diagnostic Microbiology and Infectious Disease
|
July 13, 2004
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003)
Ronald N Jones, Lalitagauri Deshpande, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease
|
January 11, 2017
Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014)
Helio S Sader, Mariana Castanheira, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
July 13, 2019
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015-2017)
Helio S Sader, Mariana Castanheira, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy
|
August 12, 2020
<i>In Vitro</i> Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe
Cecilia G Carvalhaes, Leonard R Duncan, Wen Wang, et al.
Journal of Global Antimicrobial Resistance
|
June 11, 2025
Activity of Aztreonam-avibactam and Ceftazidime-avibactam against β-lactamase-producing Enterobacterales Isolates from United States Hospitals
Lalitagauri M Deshpande, Timothy B Doyle, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2011
Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes
Helio S Sader, Paul R Rhomberg, David J Farrell, et al.
Pathology
|
July 17, 2010
Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008)
Jan M Bell, John D Turnidge, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
December 21, 2002
Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers
Helio S Sader, Ronald N Jones, Soraya Andrade-Baiocchi, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009-2013)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
February 18, 2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012)
Robert K Flamm, David J Farrell, Helio S Sader, et al.
Page
of 42